EIF4G1 and colorectal cancer: Concomitantly, EIF4G1 expression is associated with the PI3K-AKT pathway in colorectal cancer [7] and it has been shown that SBI-756 blocks EIF4G1 function and inhibits AKT/mTORC1 signaling in melanoma cancers [12].